alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE>                     5


<S>                               <C>
<PERIOD-TYPE>                     12-MOS
<FISCAL-YEAR-END>                 JUN-30-1999
<PERIOD-START>                    JUL-01-1998
<PERIOD-END>                      JUN-30-1999
<CASH>                                930,642
<SECURITIES>                                0
<RECEIVABLES>                         810,922
<ALLOWANCES>                                0
<INVENTORY>                                 0
<CURRENT-ASSETS>                    4,237,670
<PP&E>                              1,549,305
<DEPRECIATION>                        423,989
<TOTAL-ASSETS>                      5,765,773
<CURRENT-LIABILITIES>               1,721,717
<BONDS>                                     0
<PREFERRED-MANDATORY>                       0
<PREFERRED>                                 0
<COMMON>                               53,457
<OTHER-SE>                          3,990,599
<TOTAL-LIABILITY-AND-EQUITY>        5,765,773
<SALES>                             9,661,036
<TOTAL-REVENUES>                    9,661,036
<CGS>                               6,305,511
<TOTAL-COSTS>                       6,305,511
<OTHER-EXPENSES>                    7,101,023
<LOSS-PROVISION>                            0
<INTEREST-EXPENSE>                          0
<INCOME-PRETAX>                    (3,707,929)
<INCOME-TAX>                            6,000
<INCOME-CONTINUING>                (3,713,929)
<DISCONTINUED>                              0
<EXTRAORDINARY>                             0
<CHANGES>                                   0
<NET-INCOME>                       (3,713,929)
<EPS-BASIC>                           (0.98)
<EPS-DILUTED>                           (0.98)



</TABLE>
|   | (1) |   | The      Company’s quarterly report on Form 10-Q for the quarter ended September      30, 2008  (the “Form 10-Q”) fully      complies with the requirements of Section 13(a) of the Securities Exchange      Act of 1934, as amended; and |   |
|--------|-----|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|

|   | (2) |   | The      information contained in the Form 10-Q fairly presents, in all material      respects, the financial condition and      results of operations of the Company. |   |
|--------|-----|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|

|                                                | DRAGON’S      LAIR HOLDINGS, INC.(Registrant)      |                                                                       |
|-----------------------------------------------------|-----------------------------------------------------------------------------------|----------------------------------------------------------------------------|
|                                                |                                                                              |                                                                       |   |
| DATE:  November      14, 2008   | By:                                                                               | /s/ Michel      Lemoine                                               |   |
|                                                |                                                                              | Michel      Lemoine                                                        |   |
|                                                |                                                                              | President,      Secretary and Treasurer(Principal      Accounting Officer) |   |
|                                                |                                                                              |                                                                       |
October 22, 1998
                         DAVIS GROWTH OPPORTUNITY FUND
                   An authorized portfolio of Davis Series, Inc.
                            Supplement to Prospectus
                                Dated May 1, 1998

     The following information supplements and should be read in conjunction
with the section of the Fund's Prospectus entitled "Adviser, Sub-Advisers, and
Distrbutor."

     Effective December 31, 1998, the sub-advisory contract for Davis Growth
Opportunity Fund ("Fund") between Davis Selected Advisers, L.P. and Tanaka
Capital Management ("Tanaka") will be terminated and Tanaka will no longer be
the sub-adviser to the Fund.  Davis Seleted Advisers, L.P. will assume all 
management responsibilities for the Fund for both invstments and business
operations.  A team consisting of both portfolio managers and research analysts
in the Research Department of Davis Selected Advisers will be responsible for 
the day-to-day management of the Fund's portfolio.
1100 degrees R

uranium rods My Rone,

bebe
nate
RRA

‘e

M6

!

BAS
ae

ON

Kony

a

KAO.
RXss
RS
fia
“a4
y

%
Yad

tie,

G

5,

{ wgeease, oil

wy |
NG fr

AatAe. ASM
at cues

BASEMENT AREA

AYPROX 70”
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 99-6928

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

versus

MICHAEL CHARLES ANITON,

Defendant - Appellant.

Appeal from the United States District Court for the Middle District of North Carolina, at Durham. N. Carlton Tilley, Jr., Chief

District Judge. (CR-93-157, CA-97-576-1)

Submitted: November 4, 1999 Decided: November 9, 1999

Before NIEMEYER, MICHAEL, and KING, Circuit Judges.

Dismissed by unpublished per curiam opinion.

Michael Charles Aniton, Appellant Pro Se. Sandra Jane Hairston,

Assistant United States Attorney, Greensboro, North Carolina, for

Appellee.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Michael Charles Aniton seeks to appeal the district court’s

order dismissing his motion filed under 28 U.S.C.A. § 2255 (West

Supp. 1999). Aniton’s case was referred to a magistrate judge pursuant to 28 U.S.C. § 636(b)(1)(B) (1994). The magistrate judge

recommended that relief be denied and advised Aniton that failure

to file timely objections to this recommendation could waive appellate review of a district court order based upon the recommendation. Despite this warning, Aniton failed to object to the

magistrate judge’s recommendation.

The timely filing of objections to a magistrate judge’s

recommendation is necessary to preserve appellate review of the

substance of that recommendation when the parties have been warned

that failure to object will waive appellate review. See Wright v.

Collins, 766 F.2d 841, 845-46 (4th Cir. 1985); see also Thomas v.

Arn, 474 U.S. 140 (1985). Aniton has waived appellate review by

failing to file objections after receiving proper notice. We

accordingly deny a certificate of appealability and dismiss the

appeal. We dispense with oral argument because the facts and legal

contentions are adequately presented in the materials before the

court and argument would not aid the decisional process.

DISMISSED
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service 

National Institute for Occupational 

 Safety and Health 

Robert A. Taft Laboratories

 4676 Columbia Parkway 

Cincinnati, OH 45226-1998 

Phone: 513-533-6825 

Fax: 513-533-6826 

SEC Tracking Number: 0066 

March 8, 2007 

Peter M. Turcic, Director 

Division of Energy Employees Occupational 

Illness Compensation 

U.S. Department of Labor 

Room C-4511 

200 Constitution Avenue, N.W. 

Washington, D.C. 20210 

Dear Mr. Turcic: 

On behalf of the Secretary of the Department of Health and Human Services (HHS), and as 

required by 42 C.F.R. § 83.17(c), I am notifying you of the final effect of the HHS decision 

to designate a class of employees at the Harshaw Harvard-Denison Plant, Cleveland, Ohio, 

as an addition to the Special Exposure Cohort (SEC) under the Energy Employees 

Occupational Illness Compensation Program Act of 2000. On February 1, 2007, as 

provided for under 42 U.S.C. 7384q(b), the Secretary of HHS designated the following 

class of employees as an addition to the SEC: 

Atomic Weapons employees who were monitored or should have been monitored 

while working at the Harshaw Harvard-Denison Plant located at 1000 Harvard 

Avenue in Cleveland, Ohio from August 14, 1942 through November 30, 1949, and 

who were employed for a number of work days aggregating at least 250 work days 

or in combination with work days within the parameters established for one or more 

other classes of employees in the Special Exposure Cohort. 

This designation became effective on March 3, 2007, as provided for under 42 U.S.C. 

7384l(14)(C). Hence, beginning on March 3, 2007, members of this class of employees, 

defined as reported in this notice, became members of the SEC. 
 

 

 

 

 

Sincerely,

 Larry J. Elliott 

Director

 Office of Compensation Analysis and Support 

 National Institute for Occupational Safety and Health
Presidential Documents

12259 

Federal Register 

Vol. 73, No. 46 

Friday, March 7, 2008 

Title 3— 

The President 

Presidential Determination No. 2008–13 of February 28, 2008 

Waiver of Restriction on Providing Funds to the Palestinian 

Authority 

Memorandum for the Secretary of State 

By the authority vested in me as President by the Constitution and the 

laws of the United States of America, including section 650(b) of the Department of State, Foreign Operations, and Related Programs Appropriations 

Act, 2008 (Division J, Public Law 110–161) (the ‘‘Act’’), I hereby certify 

that it is important to the national security interests of the United States 

to waive the provisions of section 650(a) of the Act, in order to provide 

funds appropriated to carry out chapter 4 of part II of the Foreign Assistance 

Act of 1961, as amended, to the Palestinian Authority. 

You are directed to transmit this determination to the Congress, with a 

report pursuant to section 650(d) of the Act, and to publish the determination 

in the Federal Register. 

THE WHITE HOUSE, 

Washington, February 28, 2008. 

[FR Doc. 08–990 

Filed 3–6–08; 8:45 am] 

Billing code 4710–10–P 


jlentini on PROD1PC65 with FRO0GWBOLD.EPS</GPH>
Exhibit 10.8


Letter of Confirmation of Interest of Related Party Loans





Party A: Universal Solar Technology, Inc.


Party B: Ling Chen





Whereas:


1.
Party A is a public company trading on OTC BB;


2.
Party B is Director of Party A;





Party A and Party B agree that all loans provided by Party B to Party A will bear interest at the interest rate of 3.50% per annum since January 1, 2011. Party A can make payment of accrued interest when its cash flow circumstance allows.





Party A: Universal Solar Technology, Inc./s/ Wensheng ChenParty B: Ling Chen/s/ Ling Chen
EXHIBIT 31.1

                  CERTIFICATION PURSUANT TO 18 U.S.C. ss. 1350,
      AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Steven Berman, certify that:

1.  I have  reviewed  this  quarterly  report  on  Form  10-Q  of  China  Wi-Max
Communications, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact  necessary to make the statements
made, in light of the  circumstances  under which such statements were made, not
misleading with respect to the period covered by this quarterly report;

3.  Based  on my  knowledge,  the  financial  statements,  and  other  financial
information included in this report, fairly present in all material respects the
financial  condition,  results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4. I am responsible for  establishing  and maintaining  disclosure  controls and
procedures  (as  defined  in  Exchange  Act Rules  13a-14  and  15d-14)  for the
registrant and I have:

    a)     designed  such  disclosure  controls  and  procedures  to ensure that
           material  information  relating  to  the  registrant,  including  its
           consolidated subsidiaries, is made known to us by others within those
           entities,  particularly  during the  period in which  this  quarterly
           report is being prepared;

    b)     evaluated the effectiveness of the registrant's  disclosure  controls
           and  procedures  as of a date within 90 days prior to the filing date
           of this quarterly report (the "Evaluation Date"); and

    c)     presented in this report our conclusions about the effectiveness of
           the disclosure controls and procedures based on our evaluation as of
           the Evaluation Date;

5. The registrant's other certifying officer and I have disclosed,  based on our
most recent evaluation,  to the registrant's auditors and the audit committee of
registrant's board of directors (or persons performing the equivalent function):

    a)     all  significant  deficiencies in the design or operation of internal
           controls which could  adversely  affect the  registrant's  ability to
           record,  process,  summarize  and  report  financial  data  and  have
           identified for the registrant's  auditors any material  weaknesses in
           internal controls; and

    b)     any fraud, whether or not material, that involves management or other
           employees who have a  significant role in  the  registrant's internal
           controls; and

6. The registrant's other certifying officer and I have indicated in this report
whether or not there were significant  changes in internal  controls or in other
factors that could significantly affect internal controls subsequent to the date
of our most recent  evaluation,  including any corrective actions with regard to
significant deficiencies and material weaknesses.

Date: May 15, 2009


By:      /s/ Steven Berman
         ----------------------------------
         Steven Berman
         Chief Executive Officer
EXHIBIT 32.1


        CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906
           OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C SECTION 1350)


In connection with the Annual Report of Lifestream Technologies, Inc., a Nevada
corporation (the "Company"), on Form 10-KSB for the fiscal year ended June 30,
2003, as filed with the United States Securities and Exchange Commission (the
"Report"), I, Christopher Maus, Chief Executive Officer of the Company, certify,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section
1350), that:

(1)      The Report fully complies with the requirements of section 13(a) or
         15(d) of the Securities Exchange Act of 1934; and

(2)      The information contained in the Report fairly presents, in all
         material respects, the financial condition and results of operations of
         the Company.

/s/  Christopher Maus
------------------------
     Christopher Maus
Chief Executive Officer

September 30, 2003

[A signed original of this written statement required by Section 906 has been
provided to Lifestream Technologies, Inc. and will be retained by Lifestream
Technologies, Inc. and furnished to the United States Securities and Exchange
Commission or its staff upon request.]
EXHIBIT 32


CERTIFICATION PURSUANT TO SECTION 906

Pursuant to 18 U.S.C. Section 1350 as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, I, the
undersigned officer of the Pinewood Acquisition Corporation
(the "Company"), hereby certify to my knowledge that:

The Report on Form 10-Q for the quarter ended March 31,
2011 of the Company fully complies, in all material respects,
with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, and the information contained in the
Report fairly represents, in all material respects, the
financial condition and results of operations of the Company.

A signed original of this written statement required by Section
906 has been provided to the Company and will be retained by
the Company and furnished to the Securities and Exchange
Commission or its staff upon request.


                             /s/ Martin Hudec
                                 President, Director,
                                 Chief Executivie Officer,
                                 Chief Financial Officer and
                                 Principal Accounting Officer
Date: May 14, 2011
[Federal Register Volume 73, Number 43 (Tuesday, March 4, 2008)]
[Notices]
[Page 11637]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-966]


=======================================================================
-----------------------------------------------------------------------

EXPORT-IMPORT BANK


Sunshine Act Meeting

ACTION: Notice of a Partially Open Meeting of the Board of Directors of 
the Export-Import Bank of the United States.

Time and Place: Friday, March 7, 2008 at 11 a.m. The meeting will be 
held at Ex-Im Bank in Room 1143, 811 Vermont Avenue, NW., Washington, 
DC 20571.

Open Agenda Items: Item No. 1: Local Cost Policy, OECD Rule Change.

Public Participation: The meeting will be open to public participation 
for Item No. 1 only.

FOR FURTHER INFORMATION CONTACT: For further information, contact: 
Office of the Secretary, 811 Vermont Avenue, NW., Washington, DC 20571 
(Tele. No. 202-565-3957).

Howard A. Schweitzer,
General Counsel.
[FR Doc. 08-966 Filed 2-29-08; 3:43 pm]
BILLING CODE 6690-07-M
EXHIBIT 32


                            CERTIFICATION PURSUANT TO
                            18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


     In  connection  with the  Quarterly  Report of Gulfstar  Energy,  Inc. (the
"Company")  on Form 10-Q for the period  ending  June 30, 2010 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"). I, Robert,
President of the company,  certify,  pursuant to 18 USC Section 1350, as adopted
pursuant to Section 906 of the  Sarbanes-Oxley  Act of 2002, that to the best of
my knowledge and belief.

        (1)     The Report fully complies with the requirements of Section 13(a)
                or 15(d) of the Securities Exchange Act of 1934; and

        (2)     The information  contained in the Report fairly presents, in all
                material  respects,  the  financial  condition  and  results  of
                operations of the Company.


                                         /s/Robert McCann
                                         --------------------------------
                                         Robert McCann, President
Date: October 6, 2010
Federal Register / Vol. 73, No. 33 / Tuesday, February 19, 2008 / Notices 9127 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[FDA No. 225–07–3002] 

Memorandum of Understanding 

Between the Walter Reed Army 

Institute for Research, the Food and 

Drug Administration, and the F. 

Edward Herbert School of Medicine of 

the Uniformed Services University of 

the Health Sciences 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is providing 

notice of a memorandum of 

understanding (MOU) between the 

Walter Reed Army Institute of Research, 

FDA, and the F. Edward Herbert School 

of Medicine of the Uniformed Services 

University of the Health Sciences. This 

MOU identifies the terms of 

collaboration between the three Federal 

entities in the coordination of the 

established Clinical Pharmacology 

Fellowship Training Program. 

Specifically, this collaboration provides 

for active duty Army, Air Force, Navy, 

and Public Health Service Medical 

Corps officers in the fellowship program 

to arrange a 2 to 4 month internship 

within FDA’s Center for Drug 

Evaluation and Research (CDER) 

through CDER’s Office of Clinical 

Pharmacology. 

DATES: The agreement became effective 

January 8, 2008. 

FOR FURTHER INFORMATION CONTACT: 

Shiew Mei Huang, Center for Drug 

Evaluation and Research, Food and 

Drug Administration, 10903 New 

Hampshire Ave., Bldg. 21, Silver Spring, 

MD 20993, 301–796–1541. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 20.108(c), 

which states that all written agreements 

and MOUs between FDA and others 

shall be published in the Federal 

Register, the agency is publishing notice 

of this MOU. 

Dated: February 8, 2008. 

Jeffrey Shuren, 

Assistant Commissioner for Policy. 

BILLING CODE 4160–01–S 

mstockstill on PROD1PC66 with NOTICES

9128 Federal Register / Vol. 73, No. 33 / Tuesday, February 19, 2008 / Notices 


mstockstill on PROD1PC66 with NOTICESEN19FE08.004</GPH>
Federal Register / Vol. 73, No. 33 / Tuesday, February 19, 2008 / Notices 9129 


mstockstill on PROD1PC66 with NOTICESEN19FE08.005</GPH>
9130 Federal Register / Vol. 73, No. 33 / Tuesday, February 19, 2008 / Notices 


mstockstill on PROD1PC66 with NOTICESEN19FE08.006</GPH>
Federal Register / Vol. 73, No. 33 / Tuesday, February 19, 2008 / Notices 9131 


mstockstill on PROD1PC66 with NOTICESEN19FE08.007</GPH>
9132 Federal Register / Vol. 73, No. 33 / Tuesday, February 19, 2008 / Notices 

[FR Doc. 08–685 Filed 2–15–08; 8:45 am] 

BILLING CODE 4160–01–C 


mstockstill on PROD1PC66 with NOTICESEN19FE08.008</GPH>
1

The Honorable Joan N. Ericksen, United States District Judge for the District

of Minnesota, adopting the report and recommendations of the Honorable Susan

Richard Nelson, United States Magistrate Judge for the District of Minnesota.

United States Court of Appeals

FOR THE EIGHTH CIRCUIT

___________

No. 07-1985

___________

United States of America, *

*

Appellee, * Appeal from the United States

* District Court for the 

v. * District of Minnesota.

*

Onas Barr, * [UNPUBLISHED]

*

Appellant. *

___________

Submitted: April 3, 2008

Filed: April 10, 2008

___________

Before BYE, SMITH, and BENTON, Circuit Judges.

___________

PER CURIAM.

Federal inmate Onas Barr appeals the district court’s1

 order committing him

under 18 U.S.C. § 4245, which provides for the hospitalization of an imprisoned

person suffering from a mental disease or defect, until he no longer needs treatment

or his prison sentence expires, whichever occurs first. Following careful review, we

conclude that the district court’s section 4245 finding was supported by the unrefuted

opinion of the mental health professionals at the Federal Medical Center in Rochester,
-2-

Minnesota, and was not clearly erroneous, notwithstanding Barr’s denial of mental

illness. See 18 U.S.C. § 4245(d) (determination of mental illness and treatment need,

and burden of proof); United States v. Bean, 373 F.3d 877, 879 (8th Cir. 2004)

(standard of review); United States v. Eckerson, 299 F.3d 913, 914-15 (8th Cir. 2002)

(per curiam) (upholding commitment order based on opinion of prison hospital staff,

despite inmate’s denial of mental illness). 

Accordingly, we affirm the judgment of the district court, grant counsel’s

motion to withdraw, and deny Barr’s motion.

______________________________